首页 | 官方网站   微博 | 高级检索  
     

美罗培南治疗耐药菌感染的临床研究
引用本文:崔维,王龙安.美罗培南治疗耐药菌感染的临床研究[J].黑龙江医药科学,2014,37(5):29-30.
作者姓名:崔维  王龙安
作者单位:1. 河南中医学院第三附属医院内科,河南郑州,450003
2. 河南省人民医院EICU,河南郑州,450003
摘    要:目的:评价美罗培南在治疗耐药菌感染时的临床疗效和安全性.方法:观察本院426例住院患者给予美罗培南和亚胺培南/西司他丁后的治疗效果和不良反应.美罗培南组每日给予美罗培南0.5~1g,分2~3次给药,每次经30min静脉滴注;亚胺培南/西司他丁组每日给予亚胺培南/西司他丁0.5~1g,分2~3次,每次经30min静脉滴注.结果:美罗培南组的治愈率为77.65%,有效率为87.67%,细菌清除率87.87%;亚胺培南/西司他丁组治愈率为77.04%,有效率为87.09%,细菌清除率85.26%.两组药物结果无统计学差异.结论:美罗培南治疗耐药细菌感染有良好的临床疗效,且安全性良好.

关 键 词:美罗培南  耐药菌  临床疗效

A clinical study on Meropenem in the treatment of drug resistant bacteria infection
CUI Wei,WANG Long-an.A clinical study on Meropenem in the treatment of drug resistant bacteria infection[J].Heilongjiang Medicine and Pharmacy,2014,37(5):29-30.
Authors:CUI Wei  WANG Long-an
Affiliation:CUI Wei , WANG Long - an (1. The Third Affiliated Hospital of Henan College of Traditional Chinese Medicine, Zhengzhou 450003, China ; 2. Henan Provincial People' s Hospital, Zhengzhou 450003,China)
Abstract:Objective: To evaluate the clinical efficacy and safety of Meropenem on the treatment of resis- tant bacteria infections. Methods: We observed the efficacy and adverse reactions of 426 hospital inpatients given meropenem and imipenem/cilastatin. Patients in meropenem group and imipenem/cilastatin group were given meropenem and imipenem/eilastatin, respectively, 0. 5-1g one day, 2--3 divided doses, each time iv drip in 30min. Results: The cure rate of meropenem group was 77.65%, the effective rate was 87.67%, and the bacterial clearance rate was 87. 87%. The cure rate of imipenem/cilastatin group was 77. 04 %, the effective rate was 87.09%, and the bacterial clearance rate 85.26%. There is no significant difference between two groups. Conclusion: Meropenem shows good clinical efficacy and safety in the treatment of drug--resistant bacterial infections.
Keywords:Meropenem  resistant bacteria  clinical efficacy
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号